Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- KTWO -8%, CASY -5.5%, (also announces $300 mln share repurchase)
- LPCN -4.6%, (also entered into a Controlled Equity Offering with Cantor - may offer and sell shares of common stock having an aggregate offering price of up to $20 mln)
- AKBA -4.4%, ALOG -4.2%, THO -3.8%, KLXI -3.5%, NAV -2.9%,DAVE -2.7%, KFY -2.7%, ASNA -2.4%, DKS -2.3%, NEWT -1%,CLLS -0.8%, AMID -0.6%
M&A news:
- P -3.8% (Hollywood Reporter discusses comments from Liberty Media exec who indicated that Pandora (P) is not an attractive takeover target at today's valuation), .
Select EU financial names showing weakness:
- DB -1.7%, CS -0.9%, LYG -0.9%, BBVA -0.7%
Select metals/mining stocks trading lower:
- DRD -2.6%, MUX -2.3%, AUY -1.6%, SBGL -1.2%, GDX -1.2%, ABX-1.1%, NEM -0.9%, AU -0.6%, HMY -0.5%
Other news:
- PCRX -4.9% (announces proposed offering of $300 million aggregate principal amount of convertible senior notes)
- HASI -3.7% (prices 3 mln shares of common stock for proceeds of $58 mln)
- STAY -2.8% (prices secondary offering and repurchase of paired shares resulting in gross proceeds of $421 mln)
- SNAP -2.6% (continued weakness)
- FRC -1.6% ( agrees to sell 2,000,000 shares of its common stock in an underwritten public offering)
- RDHL -1% (RedHill's co-promotion partner for the gastrointestinal drug Donnatal Concordia (CXRX) announce that a U.S. district court granted a Concordia subsidiary treble damages related to false claims made by Method Pharmaceuticals and its principal owner)
- JBT -0.9% (announces public offering of 2 mln shares of common stock)
Analyst comments:
- FTR -2.5% (downgraded to Neutral from Buy at BofA/Merrill)
- NVS -1.4% (downgraded to Underperform from Neutral at Exane BNP Paribas)